title: [Rhabdomyosarcoma of the genitourinary sinus in children].
abstract: Genitourinary rhabdomyosarcoma (RMS) accounts for approximately 25% of all rhabdomyosarcomas. Management of RMS at this site has changed during the last 5 consecutive Intergroup Rhabdomyosarcoma (IRS) trials, with increasing emphasis of bladder and vaginal conservation. As more effective treatment regimens has improved survival, surgical approaches have evolved to less aggressive management of the primary tumour to improve conservation. Various combinations of chemotherapy, irradiation and surgery have resulted in a decreased late sequelae in the group of patients with sarcoma arising in the genitourinary tract.
authors.affiliation: Service de chirurgie viscérale et urologique, Hôpital Robert Debré, 48, boulevard Sérurier, 75019 Paris, France. pascalephilippechomette@yahoo.fr
authors.forename: P
authors.initials: P
authors.lastname: Philippe-Chomette
authors.forename: D
authors.initials: D
authors.lastname: Orbach
authors.forename: H
authors.initials: H
authors.lastname: Brisse
authors.forename: Y
authors.initials: Y
authors.lastname: Aigrain
authors.forename: D
authors.initials: D
authors.lastname: Berrebi
authors.forename: A
authors.initials: A
authors.lastname: El Ghoneimi
mesh_terms: D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D012208:Rhabdomyosarcoma / Q000175:diagnosis / Q000628:therapy; D014565:Urogenital Neoplasms / Q000175:diagnosis / Q000628:therapy; D013519:Urogenital Surgical Procedures / Q000379:methods